Durata Therapeutics, Inc. IPO Research Information

Durata Therapeutics, Inc. IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Durata Therapeutics, Inc., and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Durata Therapeutics, Inc.	DRTX -	$11.00-$13.00	$9.00	$10.00	7.5 million	7/19/2012
Underwriter(s): BofA Merrill Lynch, Credit Suisse
Co-Manager(s): RBC Capital Markets, Wedbush PacGrow
Industry: Health Care
Filing(s): Filed 2012-03-22

Durata Therapeutics, Inc. Quote & Chart - Click for current quote - DRTX

About Durata Therapeutics, Inc. (adapted from Durata Therapeutics, Inc. prospectus):
They are a pharmaceutical company focused on the development and commercialization of novel therapeutics for patients with infectious diseases and acute illnesses.

This description is adapted from Durata prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as Durata "DRTX" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.